Literature DB >> 11896537

Molecular cytogenetic analysis of 10;11 rearrangements in acute myeloid leukemia.

H Van Limbergen1, B Poppe, A Janssens, R De Bock, A De Paepe, L Noens, F Speleman.   

Abstract

MLLT10 (previously called AF10) is a moderately common MLL fusion partner predominantly occurring in acute monoblastic leukemia (AML-M5). 10;11 rearrangements require at least three breaks in order to generate an in-frame MLL-MLLT10 fusion as a result of the opposite orientations of both genes on the respective chromosome arms. In this study, we describe a detailed molecular cytogenetic analysis of MLL-MLLT10 positive 10;11 rearrangements in two patients. We observed an as yet unreported chromosomal mechanism with at least four breakpoints, leading to MLL-MLLT10 gene fusion in a 24-year-old male. An inversion of 11q13-q23 with a breakpoint in the MLL gene was followed by an additional break 3' of MLL prior to insertion of the 11q segment into MLLT10. In a second patient, a 37-year-old male with AML-M5b, molecular cytogenetic analysis of an apparent 10;11 reciprocal translocation showed an intrachromosomal inversion of 3'MLLT10followed by a reciprocal translocation between 10p12 and 11q23. Review of the literature showed that all cases were the result of an inversion of either 10p or 11q followed by translocation 10p;11q or insertion of the inverted segment into MLLT10 or MLL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896537     DOI: 10.1038/sj.leu.2402397

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.

Authors:  Draga Barbaric; Todd A Alonzo; Robert B Gerbing; Soheil Meshinchi; Nyla A Heerema; Dorothy R Barnard; Beverly J Lange; William G Woods; Robert J Arceci; Franklin O Smith
Journal:  Blood       Date:  2006-12-07       Impact factor: 22.113

2.  Diagnostic tool for the identification of MLL rearrangements including unknown partner genes.

Authors:  Claus Meyer; Bjoern Schneider; Martin Reichel; Sieglinde Angermueller; Sabine Strehl; Susanne Schnittger; Claudia Schoch; Mieke W J C Jansen; Jacques J van Dongen; Rob Pieters; Oskar A Haas; Theo Dingermann; Thomas Klingebiel; Rolf Marschalek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-30       Impact factor: 11.205

3.  11q23 abnormalities in adult Chinese patients with hematological malignancies.

Authors:  Xiaoli Zhao; Shuang Li; Nianyi Li; Rong Fan; Guowei Lin; Xiaoqin Wang
Journal:  Med Oncol       Date:  2014-07-10       Impact factor: 3.064

4.  Identification of Mixed Lineage Leukemia Gene (MLL)/MLLT10 Fusion Transcripts by Reverse Transcription-PCR and Sequencing in a Case of AML With a FISH-Negative Cryptic MLL Rearrangement.

Authors:  Kiwoong Ko; Min-Jung Kwon; Hee-Yeon Woo; Hyosoon Park; Chang-Hun Park; Seung-Tae Lee; Sun-Hee Kim
Journal:  Ann Lab Med       Date:  2015-05-21       Impact factor: 3.464

5.  Molecular studies reveal MLL-MLLT10/AF10 and ARID5B-MLL gene fusions displaced in a case of infantile acute lymphoblastic leukemia with complex karyotype.

Authors:  Mitsuteru Hiwatari; Masafumi Seki; Shogo Akahoshi; Kenichi Yoshida; Satoru Miyano; Yuichi Shiraishi; Hiroko Tanaka; Kenichi Chiba; Seishi Ogawa; Junko Takita
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

6.  [Clinical features and prognosis in MLL-AF10 positive acute leukemia].

Authors:  Li'na Wang; Yazhen Qin; Jinsong Jia; Ting Zhao; Jing Wang; Shenmiao Yang; Lei Wen; Jin Lu; Xiaojun Huang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2015-10

Review 7.  DDX3X: structure, physiologic functions and cancer.

Authors:  Jie Mo; Huifang Liang; Chen Su; Pengcheng Li; Jin Chen; Bixiang Zhang
Journal:  Mol Cancer       Date:  2021-02-24       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.